Veterans' Intervention Blending NeuRomodulation and YogA for Chronic Low BackPaiN Treatment: VIBRANT

NCT ID: NCT07158567

Last Updated: 2025-09-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

PHASE3

Total Enrollment

213 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-06-01

Study Completion Date

2031-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objectives of this VA Merit application are to demonstrate efficacy of combined intermittent theta burst (iTBS) and yoga (iTBS+yoga) intervention on improving pain, function, analgesic use, self-efficacy, quality of life and well-being among Veterans with chronic low back pain (CLBP). This Merit project will directly benefit Veterans and VA Services by demonstrating efficacy of a new, non-medication treatment for Veterans with CLBP in need of non-opioid treatment options. Neuromodulation including iTBS is now offered at over 50 VA hospitals and yoga is among the complementary and integrative health programs being rolled out as a part of VAs Whole Health implementation efforts. Thus, should iTBS+yoga ultimately prove to be efficacious, VA facilities will be well-poised to offer this treatment. A novel, activity-based, non-medication treatment for Veterans with CLBP is of great need given the high prevalence of CLBP.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Significance to VA: Chronic low back pain (CLBP) is the leading cause of disability worldwide and the most common location of chronic pain among Veterans. Medications are the treatment mainstay for CLBP and yet \>50% of chronic pain patients receiving medications are treatment resistant. Lack of pain relief from medications can lead to non-prescription opioid use, opioid use disorder, and Veteran death from opioid overdose, which occurs at a higher rate than US Civilians. This Merit will directly benefit Veterans and VA Services by developing a new, neuromodulatory, non-opioid neurorehabilitation treatment for Veterans with CLBP who do not find existing options to be effective or preferable. Innovation and Impact: Yoga is an activity, and mindfulness-based behavioral intervention and is safe and recommended for CLBP. Given the room for improvement of available treatments and considering the life-threatening opioid epidemic, building an evidence base for novel, precise, non-medication approaches for pain management has high impact for VA Healthcare. The non-invasive treatment transcranial magnetic stimulation (TMS) applied to the motor cortex (M1) reduces pain and has remote effects including neuromodulation of pain pathways. Intermittent theta burst stimulation (iTBS), a type of patterned, excitatory TMS, increases M1 excitability. iTBS can prime the brain to boost the impact of interventions provided during this window of enhanced excitability. By activating the M1 through iTBS prior to participation in an evidence-based yoga program, the investigators theorize that iTBS will boost the effects of yoga resulting in improvements in pain, function and quality of life and these improvements will be sustained. The purpose of this Merit project is to demonstrate efficacy and additive effect of combined iTBS and yoga (iTBS+yoga) and vs. yoga or iTBS alone on improving pain, function, analgesic use, self-efficacy, quality of life (QOL) and well-being among Veterans with CLBP. This Merit is a natural progression of a VA RR\&D-funded SPiRE suggesting that iTBS+yoga is safe, feasible, and acceptable among Veterans of all genders with CLBP and provides preliminary evidence of improvements from pre- to post-treatment in pain and QOL. The investigators will build on this evidence and add innovation by testing the additive effects of iTBS+yoga vs. yoga and iTBS each alone. For this Merit, the investigators will complete a randomized controlled trial among 3 groups of Veterans with CLBP receiving (1) active-iTBS+yoga, (2) sham-iTBS+yoga, or (3) active-iTBS alone. Specific Aims: Aim 1 will determine efficacy and sustainability of iTBS+yoga on pain, function, analgesic use, self-efficacy, QOL and well-being among Veterans with CLBP. Aim 2 will determine acceptability of iTBS+yoga for Veterans with CLBP. Exploratory Aim 3 will examine gender and common comorbidity measures as moderators of iTBS+yoga treatment effect. Methodology: The intervention will be provided in small group settings once a week for 6 weeks. Ac-tive- or sham-iTBS will be administered immediately prior to yoga. The investigators will be using an existing, evidence-based, manualized yoga program (LoveYourBrain Yoga). The investigators will collect outcome data related to pain, function, analgesic use, self-efficacy, QOL and well-being, as well as structural MRI data for iTBS neuronavigation. Path to Translation/Implementation: Completion of this Merit project will provide preliminary data for future applications focused on treatment responsiveness and a future larger scale multi-site pragmatic effectiveness study. This Merit project will directly benefit Veterans and VA Services by developing a new, non-pharmacological neurorehabilitation treatment for Veterans with CLBP in need of non-opioid treatment options. TMS is now offered at over 50 VA hospitals nationwide for treatment-resistant depression, and yoga is among the complementary and integrative health programs being rolled out as a part of VAs nation-wide Whole Health implementation efforts. Therefore, should iTBS+yoga ultimately prove to be efficacious and effective, VA facilities will be well-poised to offer this treatment.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Low Back Pain Musculoskeletal Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

single, blind, randomized, 3 parallel group design: (1) active-iTBS+yoga, (2) sham-iTBS+yoga, and (3) active-iTBS alone
Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Caregivers Investigators Outcome Assessors
The PI, study statistician, intervention providers, and those collecting study data will be blind to treatment assignment. While participants may be able to discern whether or not they received iTBS alone because there is no yoga component (thus, the single blind), they may not be able to guess if they received active-iTBS+yoga vs. sham-iTBS. Participants will complete a blinding questionnaire after completion of the study intervention. After follow up, the study team will become unblinded to provide participants with the opportunity to complete their preferred intervention types. The study statistician will remained blinded.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

active-iTBS+yoga

real or active intermittent theta burst stimulation provided prior to participation in small group LoveYourBrain Yoga program class

Group Type EXPERIMENTAL

intermittent theta burst stimulation

Intervention Type DEVICE

Transcranial magnetic stimulation (TMS) is a non-invasive neuromodulatory treatment. TMS has been FDA cleared since 2008 for treatment resistant depression. It is now FDA cleared for a few other indications including migraine. Magnetic pulses are delivered through a coil placed on the scalp and when the magnetic field reaches brain cells, it changes to an electric current that can increase or decrease excitability depending on the treatment parameters. Intermittent theta burst stimulation (iTBS) is a type of patterned, excitatory TMS. iTBS only takes 3 minutes to deliver and is theorized to induce a window of neuroplasticity that lasts at least 1 hour. The Magventure with Magoption x100 Stimulator and associated coil the investigators are using can be set to deliver active (real) or sham (fake or inactive) TMS. The sham device is designed to look, sound and feel like real TMS.

LoveYourBrain Yoga Program

Intervention Type BEHAVIORAL

This yoga program is evidence-based, standardized and manualized. It is developed by the LoveYourBrain Foundation (www.loveyourbrain.com). Each yoga session includes 10 min of breathing exercises, 45 min of gentle yoga or stretching exercises, 15 min of guided meditation, and 20 min of facilitated discussion with psychoeducation, detailed in a manual to ensure standardization of program content across time and instructors.

sham-iTBS+yoga

fake, inactive or sham intermittent theta burst stimulation (designed to look, sound and feel like real or active stimulation) provided prior to participation in small group LoveYourBrain Yoga program class

Group Type PLACEBO_COMPARATOR

intermittent theta burst stimulation

Intervention Type DEVICE

Transcranial magnetic stimulation (TMS) is a non-invasive neuromodulatory treatment. TMS has been FDA cleared since 2008 for treatment resistant depression. It is now FDA cleared for a few other indications including migraine. Magnetic pulses are delivered through a coil placed on the scalp and when the magnetic field reaches brain cells, it changes to an electric current that can increase or decrease excitability depending on the treatment parameters. Intermittent theta burst stimulation (iTBS) is a type of patterned, excitatory TMS. iTBS only takes 3 minutes to deliver and is theorized to induce a window of neuroplasticity that lasts at least 1 hour. The Magventure with Magoption x100 Stimulator and associated coil the investigators are using can be set to deliver active (real) or sham (fake or inactive) TMS. The sham device is designed to look, sound and feel like real TMS.

LoveYourBrain Yoga Program

Intervention Type BEHAVIORAL

This yoga program is evidence-based, standardized and manualized. It is developed by the LoveYourBrain Foundation (www.loveyourbrain.com). Each yoga session includes 10 min of breathing exercises, 45 min of gentle yoga or stretching exercises, 15 min of guided meditation, and 20 min of facilitated discussion with psychoeducation, detailed in a manual to ensure standardization of program content across time and instructors.

active-iTBS alone

real or active intermittent theta burst stimulation alone (no yoga participation)

Group Type ACTIVE_COMPARATOR

intermittent theta burst stimulation

Intervention Type DEVICE

Transcranial magnetic stimulation (TMS) is a non-invasive neuromodulatory treatment. TMS has been FDA cleared since 2008 for treatment resistant depression. It is now FDA cleared for a few other indications including migraine. Magnetic pulses are delivered through a coil placed on the scalp and when the magnetic field reaches brain cells, it changes to an electric current that can increase or decrease excitability depending on the treatment parameters. Intermittent theta burst stimulation (iTBS) is a type of patterned, excitatory TMS. iTBS only takes 3 minutes to deliver and is theorized to induce a window of neuroplasticity that lasts at least 1 hour. The Magventure with Magoption x100 Stimulator and associated coil the investigators are using can be set to deliver active (real) or sham (fake or inactive) TMS. The sham device is designed to look, sound and feel like real TMS.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

intermittent theta burst stimulation

Transcranial magnetic stimulation (TMS) is a non-invasive neuromodulatory treatment. TMS has been FDA cleared since 2008 for treatment resistant depression. It is now FDA cleared for a few other indications including migraine. Magnetic pulses are delivered through a coil placed on the scalp and when the magnetic field reaches brain cells, it changes to an electric current that can increase or decrease excitability depending on the treatment parameters. Intermittent theta burst stimulation (iTBS) is a type of patterned, excitatory TMS. iTBS only takes 3 minutes to deliver and is theorized to induce a window of neuroplasticity that lasts at least 1 hour. The Magventure with Magoption x100 Stimulator and associated coil the investigators are using can be set to deliver active (real) or sham (fake or inactive) TMS. The sham device is designed to look, sound and feel like real TMS.

Intervention Type DEVICE

LoveYourBrain Yoga Program

This yoga program is evidence-based, standardized and manualized. It is developed by the LoveYourBrain Foundation (www.loveyourbrain.com). Each yoga session includes 10 min of breathing exercises, 45 min of gentle yoga or stretching exercises, 15 min of guided meditation, and 20 min of facilitated discussion with psychoeducation, detailed in a manual to ensure standardization of program content across time and instructors.

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

transcranial magnetic stimulation (TMS), Magventure yoga, hatha-based yoga

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1 mo. stability in pain management strategies.
* 22+ years of age.
* Can read and speak English.
* Able to participate in strengthening, stretching, range of motion exercise via yoga as determined by study physician.
* Chronic Low Back Pain (CLBP): pain in the low back that persists for \>6 months and is of moderate to severe intensity with a score of \>5 on specific items on the BPI demonstrating disability of at least 20% on the Oswestry Disability Index (ODI).

Exclusion Criteria

* Contraindications to iTBS/TMS (e.g. epilepsy, psychotic spectrum disorders \[i.e. bipolar, schizophrenia\], history of anoxic brain injury).
* Moderate to severe heart disease.
* Contraindications to MRI (e.g., claustrophobia, implanted ferromagnetic device such as pacemaker or cardiac defibrillator).
* Pain believed to be associated with cardiac or ischemic conditions.
* Epilepsy, active seizure disorder, personal history of a seizure or individuals with a family history of epilepsy or seizure in a first degree relative.
* Current prescription of psychostimulants (e.g., amphetamines), anticholinergics, tricyclic antidepressants, and antipsychotics or other medications that may increase their risk of having seizures.
* Intracranial lesion.
* History of ischemic or hemorrhagic stroke.
* History of moderate to severe TBI.
* History of or current psychosis not due to an external cause (e.g., due to illicit drug use).
* Other neurological conditions (e.g., neurodegenerative disorders).
* Active suicidal ideation with Columbia Suicide Severity Rating Scale(CSSRS) 3 .
* Are pregnant or nursing.
* Within 12 weeks of a major surgery/operation.
Minimum Eligible Age

22 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

VA Office of Research and Development

FED

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Amy A Herrold, PhD BA

Role: PRINCIPAL_INVESTIGATOR

Edward Hines Jr. VA Hospital, Hines, IL

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Jesse Brown VA Medical Center, Chicago, IL

Chicago, Illinois, United States

Site Status

Edward Hines Jr. VA Hospital, Hines, IL

Hines, Illinois, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Amy A Herrold, PhD BA

Role: CONTACT

(708) 202-5867

Ibuola Kale

Role: CONTACT

(708) 202-5898

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Howard S Gordon, MD

Role: primary

312-569-7331

Gabriella G Amador

Role: primary

William Wolf, PhD

Role: backup

(708) 202-5689

Related Links

Access external resources that provide additional context or updates about the study.

https://dash.nichd.nih.gov

The NICHD Data and Specimen Hub (DASH) is a centralized resource that allows researchers to share and access de-identified data

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

I01 RD000449

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

RRD2-003-24W

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Optimize Low Back Pain
NCT03859713 UNKNOWN PHASE3